
One discovery changed everything we thought we knew about autism. And mainstream medical institutions refuse to support it. We’re not waiting for them anymore. We just launched a bold plan to revolutionize autism care. Bookmark this. 70-75% of children with autism have antibodies that prevent folate from entering the brain, leading to “cerebral folate deficiency.” (1) Cerebral folate deficiency and autism are two different things. But folate is vitamin B9, and it’s vital for brain function. So researchers asked: If we can deliver vitamin B9 to the brain, can we address cerebral folate deficiency? That’s where leucovorin, a compounded formulation of vitamin B9, comes in. In 2018, our CEO John Slattery co-published a double-blind, placebo-controlled study on leucovorin and autism. The clinical data suggested that leucovorin can significantly improve communication in children with autism and language impairment. (2) Autism parents deserve the freedom to explore leucovorin for their child with a licensed provider. So we launched a telehealth platform to connect autism parents with licensed providers to explore leucovorin with an off-label prescription. Available now in all 50 states. Check it out in the thread below, or send this post to an autism parent. References: (1) Frye et al., Molecular Psychiatry, 2013 (2) Frye RE et al., Molecular Psychiatry, 2018 @NadiaElkhatib
















